KIF3A and ciliopathy: Since miR-17 inhibition slows cyst growth in ciliopathy models (Kif3a-KO and Nphp3pcy/pcy), the beneficial effects of anti-miR-17 treatment may also be observed in other forms of cystic kidney disease besides ADPKD.